Nanose Medical

Nanose Medical is a clinical-stage company developing a breath-based testing platform powered by nano-sensors and AI to accelerate patient stratification and treatment decision support. Its autonomous, point-of-care solution delivers real-time results in under 5 minutes, enabling accurate, non-invasive, and scalable clinical insights without the need for a lab or large equipment. Founded with the support of the Technion and Hadassah Medical Center, and backed by NVIDIA and Google, Nanose combines strong scientific expertise with clinical guidance to bring innovative breath tests such as DiaNose™ to market. The company’s lead program targets MASLD/MASH, addressing a critical diagnostic gap in treatment eligibility, with additional programs in lung cancer and other high-impact indications, aiming to improve early detection, and patient outcomes.